Collaborations

Verndari is a member of the UC Davis Venture Catalyst. Verndari has a laboratory at the UC Davis Medical Center in Sacramento.

UC Davis is making their faculty, facilities, and resources available to members of its Venture Catalyst. This capability ranges from basic research facilities and services, to a GMP manufacturing facility. Verndari has relationships with several staff and faculty members at UC Davis. These include:

Emir Hodzic, PhD RT-qPCR Core
Kristin Grimsrud, PhD, DVM MBP Veterinary Services
Derek Cissell, PhD, DVM Veterinary School
Peter Barry, PhD Center for Comparative Medicine
William Chang, PhD, DVM Center for Comparative Medicine
Gerhard Bauer GMP Facility P1 and P2 materials
Steven Lucero TEAM Lab, Biomedical Engineering UCD

 

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. D. R. Henderson
Chief Executive Officer

Dan has experience and success in founding and building biopharmaceutical companies. He holds a Ph.D. in Medical Sciences from the University of New Mexico School of Medicine and was a postdoctoral scholar at Duke University Medical Center. He founded Microgenics Corporation. At Microgenics, Dan invented the CEDIA™ immunoassay system used in clinical laboratories throughout the world. CEDIA™ immunoassays now sell over $1B annually: please see www.usdiagnostics.roche.com and then search for CEDIA™ on their website; repeat at www.thermofisher.com. For this work, the American Association for Clinical Chemistry (AACC) awarded the 2015 biennial Ullman Prize for Technology Innovation to Dr. Henderson.

Dan also founded Calydon where he genetically engineered adenovirus targeting prostate cancer. For this work he was recognized as one of the two pioneers in the field of oncolytic virotherapy (Scientific American, “Tumor Busting Viruses”, October 2003). Calydon was sold to Cell Genesys. 2015 saw the first FDA approved oncolytic virus, a herpesvirus for melanoma.

Dr. Henderson also co-founded PaxVax, a manufacturer and developer of vaccines for travelers to countries without adequate water sanitation (Typhoid, Cholera and Hepatitis A) and the U.S. Military (Anthrax) (see www.paxvax.com). PaxVax was named Best Early-Stage Vaccine Biotech company at the 16th annual World Vaccine Congress in Washington, D.C., March, 2016 and received FDA approval for a Single Dose Oral Cholera vaccine in June. Dan holds 34 issued US Patents.

read more